NIH-funded research NIH-funded research

Understanding how certain bacteria interact with host cells

Official title: Regulation of the Sinorhizobium meliloti ExoS/ChvI signaling pathway critical for host infection

Funded at California State University Fullerton · NIH-10908372 · Data updated 2026-11-12

This study is looking at how a specific signaling pathway in a type of bacteria affects its ability to interact with plants and animals, which could help us understand how these bacteria can either cause problems or help their hosts.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCalifornia State University Fullerton
NIH-funded
Lab location1 site (Fullerton, United States)
Project startSeptember 20, 2021
Project endAugust 31, 2025
Funding year2024
Award (this year)$106,500
NIH project number5SC3GM144065-04
Project IDNIH-10908372 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by infections from alpha-proteobacteria such as Brucella or Bartonella.

Less likely to help

Patients who do not have infections related to alpha-proteobacteria may not benefit from this research.

What this research studies

This research investigates the ExoS/ChvI signaling pathway in Sinorhizobium meliloti, a type of bacteria that can interact with both plants and animals. By using molecular genetic techniques, the study aims to identify small RNA genes regulated by this pathway and understand how it influences the bacteria's ability to invade host cells. The findings could shed light on the mechanisms that allow these bacteria to either cause disease or form beneficial relationships with their hosts.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating infections caused by harmful bacteria.

How similar studies have gone: Other research has shown success in understanding bacterial signaling pathways, indicating that this approach has potential for meaningful insights.

Where this research is happening

  • California State University Fullerton
    Fullerton, United States
    Active

Researchers

  • Principal investigator: Chen, Esther J — California State University Fullerton
  • Study coordinator: Chen, Esther J

Related research

Other NIH-funded projects on the same topics.

  • How acetylation affects RNA-splicing decisions

    This grant looks at how chemical changes on RNA-binding proteins influence how our cells decide which RNA pieces to keep or skip, which can affect diseases like cancer and neurodegeneration.

    NIH research California State University Fullerton · Fullerton, United States · NIH-11379511

  • Cell Sorter to enable advanced cell analysis at CSUF

    A new benchtop cell sorter will help CSUF students and researchers isolate specific cell types for cancer, microbiology, neurobiology, and parasitology studies.

    NIH research California State University Fullerton · Fullerton, United States · NIH-11363155

  • Peptide-based drug leads aimed at treating botulism

    Researchers are making peptide molecules that could block the botulinum toxin and help people with botulism.

    NIH research California State University Fullerton · Fullerton, United States · NIH-11332264

  • How a common human blood protein helps Acinetobacter pick up antibiotic-resistance genes

    This project looks at whether human serum albumin, a common blood protein, makes Acinetobacter bacteria more likely to grab genes that cause antibiotic resistance, which matters for people with these infections.

    NIH research California State University Fullerton · Fullerton, United States · NIH-11111361

  • Developing new non-opioid medications for chronic pain relief

    This study is looking for new ways to help people with chronic pain by creating special medications that work on two key enzymes, which could provide better pain relief without the side effects of traditional treatments, and patients may have the chance to try these new options in trials.

    NIH research California State University Fullerton · Fullerton, United States · NIH-11089497

  • Developing new treatments for botulism using synthetic molecules

    This study is working on developing new treatments for botulism, a serious illness caused by a harmful toxin, by testing small molecules to see if they can stop the toxin from causing harm.

    NIH research California State University Fullerton · Fullerton, United States · NIH-11074142

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.